![Olivier Tillement](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Olivier Tillement is the founder of NH TherAguix SAS, holding the title of Director since 2019, founded in 2015.
Dr. Tillement was the founder of Mexbrain SAS, having held the title of Chief Scientific Officer, founded in 2017.
Dr. Tillement is currently a Professor at Université Claude Bernard Lyon 1.
Postes actifs de Olivier Tillement
| Sociétés | Poste | Début |
|---|---|---|
| NH THERAGUIX SAS | Fondateur | 11/12/2015 |
Université Claude Bernard Lyon 1
 Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Olivier Tillement
| Sociétés | Poste | Fin |
|---|---|---|
Mexbrain SAS
 Mexbrain SAS Medical SpecialtiesHealth Technology Manufactures therapeutic dialysis devices for metal extraction | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Université Claude Bernard Lyon 1
Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NH TherAguix SAS
 NH TherAguix SAS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops nanomedicine for cancer, combining imaging and radiotherapy | Health Technology |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Manufactures therapeutic dialysis devices for metal extraction | Health Technology |
